Teresa Coons

Professor Teresa A. Coons is an Assistant Professor Adjunct in the Department of CSPH-Epidemiology General Operations at the University of Colorado Denver, Anschutz Medical Campus. She is dedicated to building collaborative efforts in the field of epidemiology, with a particular focus on lung cancer research. Her work is centered on identifying genetic susceptibility genes associated with lung cancer, especially in populations of light and never smokers, which is a crucial area of study given the rising incidence of lung cancer in these groups. Professor Coons has been successful in securing funding for her research from prestigious institutions such as the National Institutes of Health (NIH). Her research contributions have been widely recognized and published in several high-impact, peer-reviewed journals. Some of her notable publications can be found in Cancer Research, the Journal of Thoracic Oncology, and the American Journal of Human Genetics. These publications highlight her commitment to advancing the understanding of genetic factors in lung cancer and her ability to translate complex genetic data into actionable insights for cancer prevention and treatment. In addition to her research endeavors, Professor Coons is actively involved in mentoring students and young researchers, fostering a new generation of scientists who are equipped to tackle the challenges of cancer epidemiology. Her teaching philosophy emphasizes the importance of interdisciplinary collaboration and the integration of cutting-edge research techniques into the educational experience. Professor Coons's dedication to her field is evident not only in her research and teaching but also in her active participation in various professional organizations related to epidemiology and oncology. She frequently presents her findings at national and international conferences, contributing to the global dialogue on cancer research and prevention strategies. Through her work, Professor Coons continues to make significant strides in understanding the genetic underpinnings of lung cancer, ultimately aiming to improve patient outcomes and inform public health policies. Her efforts in building collaborative networks and advancing research methodologies underscore her commitment to the fight against cancer.